Key result
One week of free fatty acid lowering with acipimox significantly reduced ejection fraction (56% vs 62%, P=0.0035) and cardiac output, but improved insulin sensitivity by 33%.
Why the study?
Does lowering free fatty acids with acipimox alter cardiac function and insulin sensitivity in adult subjects?
Does lowering free fatty acids with acipimox alter cardiac function and insulin sensitivity in adult subjects?
Absolute Event Rate: 56% vs 62%
p-value: p=0.0035
A 1-week depletion of free fatty acids with acipimox suppressed cardiac function but improved insulin sensitivity, independent of myocardial triglyceride deposits.
Acipimox-associated FFA lowering may reduce EF while improving insulin sensitivity; hypothesis-generating and should not yet change practice.
BACKGROUND/AIM: We tested the hypothesis that a persistent reduction in free fatty acid (FFA) levels improves cardiac function and systemic insulin sensitivity via a reduction in the myocardial and skeletal muscle adiposities and a modulation in adipokine release. METHODS: Study subjects (body mass index 22-30 kg/m(2), 57 ± 3 yr old) underwent magnetic resonance imaging and spectroscopy to measure the cardiac function and the amounts of fat inside and around the myocardium and skeletal muscle, before (n = 10) and after acute (n = 8) and 1 wk (n = 7, one excluded from analysis) lowering of circulating FFA by acipimox. Circulating adipokines (leptin, adiponectin, resistin, TNFα, IL-6, IL-8, plasminogen activator inhibitor-I, macrophage chemoattractant protein-1) were measured. RESULTS: The ejection fraction (62 ± 2 vs. 56 ± 1%, P = 0.0035), cardiac output (6.6 ± 0.3 vs. 5.5 ± 0.2 liters/min, P = 0.0018), and forward work (708 ± 49 vs. 539 ± 44 mm Hg × liters/min, P = 0.018) were significantly lower after 1 wk of FFA lowering. In the six subjects undergoing all sessions, the stroke and end-diastolic volumes were also reduced, insulin sensitivity was increased by 33%, and adiponectinemia was decreased (-26%, P = 0.03). No change in intracellular cardiac and skeletal muscle triglyceride levels was observed. Metabolic changes correlated with the lowering of FFA. The reduction in cardiac function was related with changes in glycemia and insulin sensitivity, whereas the deflection in left ventricular work was correlated with the decline in FFA, lipid, and blood pressure levels. CONCLUSIONS: A 1-wk FFA depletion suppressed cardiac function and improved insulin sensitivity. Intracellular triglyceride deposits in the heart and skeletal muscle played no role in the observed changes. Our data show that FFA participate in the physiological regulation of adipokine levels.
No takes yet. Share an insight, caveat, or question.
Lehto et al. (2012) studied this question. Acipimox vs. Baseline was evaluated on Ejection fraction (p=0.0035). One week of free fatty acid lowering with acipimox significantly reduced ejection fraction (56% vs 62%, P=0.0035) and cardiac output, but improved insulin sensitivity by 33%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: